Prion replication in spleen and neuroinvasion after i.p. inoculation of mice is impaired in forms of immunodeficiency where mature B lymphocytes are lacking. In spleens of wild-type mice, infectivity is associated with B and T lymphocytes and stroma but not with circulating lymphocytes. We generated transgenic prion protein knockout mice overexpressing prion protein in B lymphocytes and found that they failed to accumulate prions in spleen after i.p. inoculation. We conclude that splenic B lymphocytes are not prion-replication competent and that they acquire prions from other cells, most likely follicular dendritic cells with which they closely associate and whose maturation depends on them.
A blation of the prion protein (PrP) gene renders mice (Prnp 0/0 ) resistant to experimental scrapie and precludes replication of prions (2) (3) (4) . Introduction of PrP transgenes under the control of the PrP promoter into Prnp 0/0 mice restores susceptibility to scrapie (5) .
I.p. inoculation of mice with the scrapie agent results first in prion replication in spleen and subsequently in brain. Transfer of prions from periphery to the central nervous system (CNS), i.e., neuroinvasion, requires interposed PrP C -expressing tissues (6) . B cells were found to be essential for facilitating neuroinvasion after peripheral infection (1) . However, because B cells devoid of PrP also enabled neuroinvasion, it seemed that they might not replicate and transport prions but rather play an indirect role in this process (7) . Nonetheless, splenic (but not circulating) B lymphocytes are associated with prion infectivity (8) . This finding raised the question whether B cells could replicate prions or acquire them from other cells. In this paper, we report that PrP knockout mice that overexpress PrP specifically on B cells do not accumulate prions in the spleen after i.p. infection, showing that in wild-type mice they must be acquiring prions from other cells. Because follicular dendritic cells (FDCs) are essential for the propagation of prions in the spleen (9, 10) , we propose that splenic B cells acquire prions from FDCs, with which they are closely associated. Thus, at least in the mouse, B cells are not instrumental in carrying infectivity to the CNS.
Materials and Methods
Construction of PrP Expression Vectors. To construct the pHT4-PrP.cDNA͞EcoRI vector used to generate TgN(Ig Prnp) mice, the 12.4-kb SacI fragment, harboring the known control sequences (Ig promoter and enhancer) and the plasmid backbone, was isolated from pHT4-YK 12 (11), blunted with T4 DNA polymerase, and dephosphorylated. The 1.37-kb BamHI-EcoRI fragment, containing Prnp exons 1 and 2 and part of 3, was excised from pPrP͞cDNA͞EcoRI (A. Sailer, unpublished data) and blunted with T4 DNA polymerase. The two fragments were ligated.
pCD19-PrP.HG͞Sal, used to generate TgN(CD19 Prnp) mice, was constructed from four fragments. (i) A fragment containing the entire hCD19 transgene was excised with HindIII from pSP65V7.J5 (C.A.J.V., unpublished data) and inserted between the PacI and AscI restriction sites of a modified pSP65 vector (pSP65AP, F.M., unpublished data) to generate pSP65AP-hCD19. A 15.9-kb fragment (harboring the plasmid backbone), 3.7 kb of hCD19 5Ј noncoding sequences, and a 9.5-kb segment of hCD19 (comprising part of exon 4, exons 5-15, and the 3Ј noncoding sequence), were isolated from pSP65AP-hCD19 by digestion with EcoRI and KpnI. (ii) A 1.1-kb EcoRI-BamHI fragment, harboring the hCD19 proximal 5Ј noncoding sequence and exon 1 up to the BamHI site within the multiple cloning site, was excised from phCD19MCS (C.A.J.V., unpublished data). (5) . Of 10 mouse lines transgenic for the Ig construct, the line with the highest transgene mRNA expression in the spleen (TgN306) was examined further. Of four mouse lines transgenic for the human CD19 construct, the one with the highest PrP C expression on peripheral blood lymphocytes (TgN431) was used for further experiments.
mM EDTA (pH 8)͞0.1% sodium azide (FACS buffer). Leukocytes were pelleted for 10 min at 200 ϫ g. Erythrocytes were lysed with FACS lysing solution (Becton Dickinson) according to the manufacturer's protocol. Single staining for PrP was achieved by incubation of peripheral blood leucocytes for 30 min at 4°C with 100 l of monoclonal 6H4 antibody (13) (1:100; Prionics AG, Zürich). Cells were washed in cold FACS buffer, stained for 30 min at 4°C with 100 l of goat anti-mouse IgG1-FITC (1:100; Southern Biotechnology Associates), and washed again before cytofluorometry (Becton Dickinson FACScan). For two-color FACS analyses, PrP staining was followed by B cell staining with phycoerythrin (PE)-conjugated anti-B220 antibodies (1:100; PE anti-mouse CD45R͞B220, PharMingen) or T cell staining with PE-conjugated anti-CD3e antibodies (1:100; PE anti-mouse CD3e, PharMingen) for 15 min at 4°C. Before cytofluorometry, erythrocytes were lysed with FACS lysing solution (Becton Dickinson) by following the manufacturer's protocol. The lymphocyte population was gated for analysis on the basis of forward scatter and side scatter.
Immunoprecipitation. Homogenates (10% wt͞vol) from fresh or frozen tissues were prepared in 1 ϫ SaB buffer (Prionics AG, Zürich). The homogenates were centrifuged for 15 min at 400 ϫ g. Supernatants were transferred to Eppendorf tubes, diluted to 2% with PBS, and either 500-or 250-l aliquots (corresponding to 10 and 5 mg of spleen, respectively) were preadsorbed with 50 l of blocked Sepharose 4B beads (Amersham Pharmacia Biotech) by incubation at 4°C for 30 min on a rocking platform. To the preadsorbed samples, 100 l of Sepharose 4B beads linked to monoclonal antibody 6H4 (13) were added, and samples were incubated overnight at 4°C on a rocking platform. Sepharose beads were washed twice with 50 mM Tris⅐HCl, pH 7.5͞150 mM NaCl͞1% (vol/vol) Nonidet P-40͞0.5% sodium deoxycholate͞1 mM EDTA, pH 7.5͞1 mM PMSF; twice with 50 mM Tris⅐HCl, pH 7.5͞500 mM NaCl͞0.1% Nonidet P-40͞0.05% sodium deoxycholate; and finally once with 50 mM Tris⅐HCl, pH 7.5͞0.1% Nonidet P-40͞0.05% sodium deoxycholate. Pellets were boiled in SDS sample buffer and analyzed by immunoblotting.
Western Blot Analysis. One hundred twenty micrograms of total protein of each brain homogenate and the equivalent of either 5 or 10 mg of spleen after immunoprecipitation were electrophoresed through a 12.5% SDS polyacrylamide gel. Proteins were transferred to nitrocellulose membranes by wet blotting. Membranes were blocked with Tris-buffered saline ϩ Tween 20 (0.05%)͞5% nonfat dry milk, incubated with 1B3 rabbit polyclonal anti-PrP serum (14) , and bands were visualized by enhanced chemiluminescence (Amersham Pharmacia). Quantification was by laser densitometry (Molecular Dynamics) of appropriately exposed films. Infectivity Bioassay. Spleen homogenates [10% (vol͞vol) in 0.32 M sucrose] were prepared from infected animals as described (15) . Thirty microliters of 1% vol͞vol homogenates [in PBS͞5% BSA] were administered intracerebrally to groups of four tga20 mice for each sample. Incubation time to terminal scrapie sickness was determined and infectivity titers were calculated by using either the relationship y ϭ 14.37Ϫ0.11x (for RML 4.0) or y ϭ 11.45Ϫ0.088x (for RML 4.1), where y is the ID 50 , and x is the incubation time (in days) to terminal disease.
Results
PrP Knockout Mice Expressing PrP C on B Lymphocytes. To investigate whether expression of PrP in B lymphocytes is sufficient to enable scrapie replication in Prnp 0/0 mice, we generated two types of transgenic mice in which the PrP-encoding sequence was expressed in B cells. TgN(Ig Prnp) transgenic mice were generated by placing the murine PrP ORF under the control of the Ig light chain (Ig) enhancer͞promoter, which had been shown previously to drive expression exclusively in lymphoid cells (16) . In TgN(CD19 Prnp) transgenic mice, a PrP cassette comprising the three PrP exons and the first intron, but lacking the second intron, was under the control of the human CD19 regulatory elements, known to mediate B lineage-specific expression in mice (17) .
Transgene (Fig. 1B) . There was a population of PrP-expressing B220 negative lymphocytes in TgN306 mice that we did not characterize further because, as described below, there was no propagation of prions in these mice. PrP (Fig. 2) . Prnp 0/ϩ mice showed about half the wild-type levels of PrP C . TgN306 mice had levels close to wild type (0.8 times), whereas TgN431 mice overexpressed PrP C at least 50-to 100-fold ( Table 1 ). The general architecture of the spleen was normal as was the localization of B lymphocytes in splenic follicles and germinal centers, as shown by B220 and PNA staining, respectively (data not shown).
PrP Knockout Mice Expressing PrP on B Cells Do Not Replicate Prions.
To determine whether PrP In contrast, no prion infectivity was detected in the spleens of TgN306 transgenic mice at any time tested after i.p. challenge [Ͻ1.5 logarithm (log) ID 50 units͞ml of 10% (vol͞vol) homogenate]. In the case of TgN431 mice, low prion titers [2.7 log ID 50 units͞ml of 10% (vol͞vol) homogenate] were detected 2 weeks after infection, whereas samples taken after 4 and 8 weeks caused disease in only 1 of 8 indicator mice. These traces of infectivity are caused in all likelihood by residual inoculum; similar findings have been reported for PrP knockout mice (1, 3, 6, 9) . Persistence of residual infectivity after 2 weeks in the spleens of TgN431 but not of TgN306 mice is likely because of the fact that the TgN431 mice were inoculated with an almost 10-fold higher dose of prions (see Materials and Methods).
Discussion
Mice transgenic for the PrP ORF under the control of an interferon regulatory factor-1 promoter͞E enhancer (18) , which expresses PrP in the lymphoreticular system, accumulated prions in spleen after i.p. inoculation (12) . However, Prnp 0/0 mice expressing PrP transgenes under the control of T lymphocyte-or liver-specific regulatory elements failed to replicate prions, suggesting that expression of PrP C is not sufficient to enable prion replication (12) .
Our current experiments show that CD19-directed expression of PrP C on B lymphocytes fails to sustain prion accumulation in the spleens of PrP knockout mice. Could it be that in wild type, spleen prion replication occurs in immature B cells that, in CD19-PrP transgenic animals, do not yet express PrP? This is unlikely, because CD19 transgene expression starts at the stage of pro-and preB cell development in the bone marrow (17, 19) , whereas the spleen is populated by naive, CD19-expressing mature B cells. Therefore, the result of our experiment must be attributed either to the inability of splenic B cells to replicate prions or to a failure of prions to reach the spleen in a PrP knockout mouse. However, because spleens of TgN431 mice contained prions 2 weeks after i.p. inoculation, we conclude that B lymphocytes are inherently incapable of replicating prions.
Several lines of evidence show that follicular dendritic cells are the principal sites for synthesis and accumulation of scrapiespecific PrP (PrP Sc ) and infectivity in the spleen, and that they contribute, directly or indirectly, to neuroinvasion (9, 10, (20) (21) (22) (23) . Formation and maintenance of mature FDCs require the presence of B cells expressing membrane-bound lymphotoxin-␣͞␤ (24) (25) (26) . Therefore, the requirement for B cells for prion replication in the spleen and efficient neuroinvasion (7, 27 ) may be explained readily by their essential role in the maturation of FDCs. This explanation is strengthened by the finding that B lymphocytes which lack PrP C (and are therefore inherently unable to replicate prions) can restore prion accumulation in spleen and neuroinvasion in severe combined immunodeficient (SCID), RAG-1 0/0 , and MT mice (7). Also, mice expressing PrP in the peripheral nervous system but not in leukocytes were competent in neuroinvasion from the periphery (28) .
Although mature B lymphocytes are unable to replicate prions, even when overexpressing PrP, they carry prions when isolated from spleens of wild-type mice inoculated i.p. (8) , and they accumulate scrapie-specific PrP (PrP Sc ) (A.J.R, R.F., M.A.K., A.A., and C.W., unpublished results). We therefore propose that in wild-type mice, prions associated with B cells originate from other cells, most likely FDCs. Immunoelectron microscopy reveals ubiquitous accumulation of extracellular PrP in complex glomerular dendrites of FDCs (29) . Because B cells interdigitate with FDCs, mechanical separation of B cells from the stroma-bound FDCs may result in their sequestering FDC membrane fragments with associated prions. During physiological detachment of B cells from FDCs, this would not occur, explaining why circulating B lymphocytes in scrapie-infected mice are devoid of scrapie infectivity.
